MarketPeel
Insider Trading Intelligence
KL

Kairos Venture Partners Ii, L.p.

ACTU
DIRECTOR · ACTUATE THERAPEUTICS, INC. · CIK 0001696711
FILING MIX · LIFETIME91%/9%
BUYS
21
SELLS
2
TOTAL VALUE
$1.92M
COMPANIES
1
ACTIVE SINCE
Aug 2024
HOLDINGS NOW
904,795
AVG SELL PX
$5.94
TRADE KIND
SHOWING 23 / 23
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizons · 3 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Kairos Venture Partners Ii, L.p., measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+100.00%-7.66%+2.09%-9.75%-9.75%
14d2+100.00%-12.54%+0.60%-13.15%-13.15%
30d2+100.00%-18.93%+1.57%-20.50%-20.50%
60d2+100.00%-34.10%+2.78%-36.88%-36.88%
90d2+100.00%-34.15%+2.96%-37.11%-37.11%
180d2+100.00%-40.20%+10.13%-50.32%-50.32%
1y2(1 pending)+100.00%-10.16%+19.73%-29.90%-29.90%
2y2(2 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ACTU · 904,795 shares · as of Jan 5, 2026
0300,886601,773902,6591,203,54520252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2024
2024
2025
2025
2025
2025
2026
FLOW · 21 buys / 2 sellsCOVERAGE · 7 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
280,000$5.80$1.62M904,795Jan 5, 2026Jan 7, 2026View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
49,984321,781Aug 14, 2024Aug 16, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
146,870873,033Aug 14, 2024Aug 16, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
28,464$5.27$150.0K1,203,545Aug 14, 2024Aug 16, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
138,8890Aug 14, 2024Aug 16, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
28,4640Aug 14, 2024Aug 16, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
69,4450Aug 14, 2024Aug 16, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
24,1380Aug 14, 2024Aug 16, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
132,9080Aug 14, 2024Aug 16, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
69,4451,175,081Aug 14, 2024Aug 16, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
726,1630Aug 14, 2024Aug 16, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
138,889138,889Aug 14, 2024Aug 16, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
132,908271,797Aug 14, 2024Aug 16, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
18,750$8.00$150.0K1,184,795Aug 14, 2024Aug 16, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
1,058,3181,105,636Aug 14, 2024Aug 16, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
146,8700Aug 14, 2024Aug 16, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
49,9840Aug 14, 2024Aug 16, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
726,163726,163Aug 14, 2024Aug 16, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
230,5970Aug 14, 2024Aug 16, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
1,058,3180Aug 14, 2024Aug 16, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
230,597230,597Aug 14, 2024Aug 16, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
24,138254,735Aug 14, 2024Aug 16, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
15,00015,000Aug 12, 2024Aug 16, 2024View →
Other insiders · ACTU
Loading peer insiders…
About this filer
CIK 0001696711
ROLE
Director
PRIMARY
ACTU
COMPANIES
1
ACTIVE SINCE
Aug 2024
MARKETPEEL · /INSIDER/0001696711DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback